Search

Search Constraints

You searched for: Author/Creator Graham, Carl

Search Results

1. The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study. (September 2021)

2. Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study. (January 2022)

3. Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) induces neutralising antibody and polyfunctional T‐cell responses in patients with chronic myeloid leukaemia. (3rd June 2021)

4. Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study. Issue 6 (June 2021)

5. Design, Synthesis and Discovery of N, N'‐Carbazoyl‐aryl‐urea Inhibitors of Zika NS5 Methyltransferase and Virus Replication. (7th January 2020)

7. Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE England. Issue 6 (December 2020)